RBC stock price holds near C$235 after TSX record close — what to watch before Monday
17 January 2026
2 mins read

RBC stock price holds near C$235 after TSX record close — what to watch before Monday

Toronto, Jan 17, 2026, 15:27 ET — Market closed.

  • Shares of Royal Bank of Canada ended Friday almost unchanged, mirroring a stable trend among the country’s major banks.
  • Attention turns to Canadian inflation, rate forecasts, and housing indicators that influence loan growth and credit risk.
  • RBC’s dividend schedule and new funding moves are key items on next week’s agenda.

Royal Bank of Canada (RY.TO) wrapped up Friday at C$235.42, ticking up 0.03%, while its U.S.-listed counterpart (RY) slipped 0.09% to close at $169.18. Toronto markets remain closed Saturday and will reopen Monday. (StockAnalysis)

The quiet close counts since bank stocks move on rate calculations just as much as news. Investors want to figure out how quickly borrowing costs might drop without reigniting inflation, and if a weaker economy will push loan losses higher.

Canada’s S&P/TSX Composite ticked up 0.04% to 33,040.55 on Friday, marking yet another record close. Energy shares led the gains as investors absorbed news of a Canada-China trade agreement. “Markets are rational,” noted Angelo Kourkafas, senior global investment strategist at Edward Jones. (Reuters)

The Canadian dollar slipped 0.2% to 1.3915 per U.S. dollar on Friday, hitting its lowest level since Dec. 5. Meanwhile, the Canadian 10-year yield climbed to 3.376%. “Hassett is perceived to be the most dovish of the likely candidates,” said Scotiabank chief currency strategist Shaun Osborne, referencing speculation about the next U.S. Federal Reserve chair. (Reuters)

RBC announced it has issued 1 billion euros in floating-rate callable senior notes maturing in January 2030, along with 750 million euros of fixed-to-floating callable senior notes due February 2032. The “callable” feature allows the bank to repay the debt early, usually to take advantage of cheaper refinancing options down the line. (Investegate)

Housing is still a major factor for lenders. Canadian housing starts climbed 5.6% in 2025, yet CMHC chief economist Mathieu Laberge cautioned that “since September, the trend in housing starts has consistently decreased,” despite the Bank of Canada’s benchmark rate holding at 2.25%. (Reuters)

RBC faces a dividend date likely to influence short-term trading. The stock goes ex-dividend on Jan. 26, so anyone buying after won’t get the upcoming payout. That dividend is set at C$1.64 per share, payable on Feb. 24. (StockAnalysis)

Monday’s the next big hurdle: Statistics Canada will drop the December consumer price index. Inflation numbers can pivot rate forecasts sharply, often rattling the big banks right away. (Statistics Canada)

The Bank of Canada’s calendar zeroes in on key dates later this month. The Business Outlook Survey drops on Jan. 19, followed by the policy announcement on Jan. 28 at 09:45 ET. (Bank of Canada)

The situation remains unsettled. Canada’s easing on tariffs for Chinese electric vehicles has drawn criticism from some members of U.S. President Donald Trump’s cabinet. This episode highlights how trade politics continue to influence markets and shake investor confidence. (Reuters)

RBC, along with Toronto-Dominion, Bank of Montreal, and Scotiabank, will be watching Monday’s inflation report closely. The next key event after that is the Bank of Canada’s rate decision on Jan. 28.

Stock Market Today

  • Solventum (SOLV) valuation signals upside as momentum cools; fair value near $85.64
    January 17, 2026, 3:55 PM EST. Solventum (SOLV) traded near $79.48, with a one-day gain of 1.19% and a week-long rise of 7.73%. Three-month return stands at 10.14%, while the one-year total shareholder return is 8.12%, suggesting momentum has cooled but not erased. A base case from Simply Wall St shows a fair value around $85.64, implying a ~40% discount to intrinsic value or a modest valuation gap. The stock carries a value score of 5 and a proposed price target about 10% higher. The company's pipeline-Negative Pressure Wound Therapy, advanced wound care, sterilization, and digital health solutions such as autonomous coding-could support long-term top-line and earnings growth amid rising demand for healthcare tech. Risks include the 3M separation, ERP rollout, and SKU rationalization that could weigh on reported growth and margins.
L’Oréal stock price dips into weekend: what to watch after Friday’s close in Paris
Previous Story

L’Oréal stock price dips into weekend: what to watch after Friday’s close in Paris

Intel stock drops into long weekend as Citi lifts rating; earnings test looms
Next Story

Intel stock drops into long weekend as Citi lifts rating; earnings test looms

Go toTop